IRIS UniCatt

De Maio, Flavio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.160
EU - Europa 3.723
AS - Asia 3.306
SA - Sud America 668
Continente sconosciuto - Info sul continente non disponibili 182
AF - Africa 110
OC - Oceania 12
Totale 13.161
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.973
SG - Singapore 1.488
IT - Italia 984
DE - Germania 755
CN - Cina 685
BR - Brasile 550
SE - Svezia 442
FR - Francia 375
VN - Vietnam 330
PL - Polonia 314
GB - Regno Unito 153
FI - Finlandia 152
IE - Irlanda 132
IN - India 110
HK - Hong Kong 108
ID - Indonesia 107
BD - Bangladesh 98
CA - Canada 98
JP - Giappone 94
UA - Ucraina 65
RU - Federazione Russa 63
AT - Austria 62
MX - Messico 53
TR - Turchia 53
AR - Argentina 51
NL - Olanda 48
IQ - Iraq 39
ZA - Sudafrica 38
ES - Italia 35
CH - Svizzera 30
KR - Corea 29
MA - Marocco 29
TW - Taiwan 25
BE - Belgio 22
CZ - Repubblica Ceca 22
IR - Iran 21
EC - Ecuador 17
PK - Pakistan 17
GR - Grecia 16
LT - Lituania 15
SA - Arabia Saudita 15
CL - Cile 13
IL - Israele 13
UZ - Uzbekistan 13
VE - Venezuela 13
CI - Costa d'Avorio 12
PH - Filippine 11
JO - Giordania 10
AU - Australia 9
JM - Giamaica 8
KE - Kenya 8
AE - Emirati Arabi Uniti 7
CO - Colombia 6
DO - Repubblica Dominicana 6
EG - Egitto 6
TN - Tunisia 6
UY - Uruguay 6
AZ - Azerbaigian 5
CR - Costa Rica 5
HU - Ungheria 5
PE - Perù 5
PY - Paraguay 5
RS - Serbia 5
DZ - Algeria 4
HN - Honduras 4
KZ - Kazakistan 4
PA - Panama 4
RO - Romania 4
BH - Bahrain 3
DK - Danimarca 3
EE - Estonia 3
KG - Kirghizistan 3
NP - Nepal 3
VA - Santa Sede (Città del Vaticano) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
BO - Bolivia 2
ET - Etiopia 2
EU - Europa 2
LA - Repubblica Popolare Democratica del Laos 2
LI - Liechtenstein 2
MY - Malesia 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SI - Slovenia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
DM - Dominica 1
GA - Gabon 1
GE - Georgia 1
Totale 12.972
Salva come PNG Salva come JPEG
Città #
Singapore 827
Ashburn 552
San Jose 486
Chandler 469
Warsaw 215
New York 191
Rome 189
Munich 157
Chicago 149
Beijing 139
Los Angeles 136
Dublin 130
The Dalles 121
Milan 108
Hong Kong 100
Ho Chi Minh City 99
Tokyo 92
Lauterbourg 91
Hefei 86
Helsinki 85
Kraków 84
Jakarta 76
Hanoi 75
Frankfurt am Main 72
Ann Arbor 69
Council Bluffs 69
Dallas 66
Fairfield 62
Wilmington 62
Cattolica 60
Boardman 59
São Paulo 59
San Mateo 55
Houston 54
Marseille 50
Seattle 48
Woodbridge 47
North Bergen 45
Boston 44
Jacksonville 44
Santa Clara 44
Vienna 44
Nanjing 43
Princeton 40
Moscow 37
Orem 33
Lappeenranta 32
Buffalo 31
Denver 31
Guangzhou 31
Nuremberg 31
Nürnberg 31
Atlanta 30
Kent 29
London 29
Montreal 28
Seoul 28
Washington 28
Appignano 27
Brooklyn 26
Phoenix 26
Cambridge 25
Chennai 25
Dearborn 22
Redwood City 22
Toronto 22
Bremen 21
Paris 21
Shanghai 21
Brussels 20
Da Nang 20
Zurich 20
Johannesburg 19
Rio de Janeiro 19
San Francisco 18
Stockholm 18
Mexico City 17
Andover 16
Dong Ket 16
Düsseldorf 16
Amsterdam 15
Falls Church 15
Izmir 15
Salt Lake City 15
Haiphong 14
Tianjin 14
Turku 14
Ankara 13
Abidjan 12
Brno 12
Iesi 12
Lawrence 12
Macerata 12
Manchester 12
Poplar 12
Augusta 11
Bexley 11
Falkenstein 11
Pune 11
Senigallia 11
Totale 6.933
Salva come PNG Salva come JPEG
Nome #
PE_PGRS33 Contributes to Mycobacterium tuberculosis Entry in Macrophages through Interaction with TLR2 359
ESISTE UNA CORRELAZIONE TRA ENERGIA, QUALITÀ DELL'ARIA INDOOR E COMFORT? L’ESPERIENZA DEL PROGETTO INTERNAZIONALE SEARCH II 351
Antifungal Susceptibility Profiles of Bloodstream Yeast Isolates by Sensititre YeastOne: a Nine-Year Experience at a Large Italian Teaching Hospital 298
Profiling the Urobiota in a Pediatric Population with Neurogenic Bladder Secondary to Spinal Dysraphism 285
Unraveling the Gut Microbiome–Diet Connection: Exploring the Impact of Digital Precision and Personalized Nutrition on Microbiota Composition and Host Physiology 284
Comparative Evaluation of BD Phoenix and Vitek 2 Systems for Species Identification of Common and Uncommon Pathogenic Yeasts 254
Optimized Use of the MALDI BioTyper System and FilmArray BCID Panel for the Direct Identification of Microbial Pathogens from Positive Blood Cultures 252
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 250
Unraveling the potential of graphene quantum dots against Mycobacterium tuberculosis infection 236
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 212
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis 212
Comparison of Mycoplasma IES, Mycofast Revolution and Mycoplasma IST2 to detect genital mycoplasmas in clinical samples. 206
3D-printed graphene polylactic acid devices resistant to SARS-CoV-2: Sunlight-mediated sterilization of additive manufactured objects 201
Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against Mycobacterium tuberculosis 198
International consensus statement on microbiome testing in clinical practice 197
Direct use of eazyplex® SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in Escherichia coli and Klebsiella pneumoniae bloodstream infections 191
Improved binding of SARS-CoV-2 Envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis 187
Impact of pe_pgrs33 gene polymorphisms on mycobacterium tuberculosis infection and pathogenesis 186
Laser-Mediated antibacterial effects of Few- and Multi-Layer Ti3C2Tx MXenes 186
Commercially available CD4 + and CD8 + IFN-γ release assays combined with an HBHA-induced IGRA improve the characterization of the tuberculosis spectrum and monitoring of treatment in children 181
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 178
Immunopathology of SARS-CoV-2 Infection: A Focus on T Regulatory and B Cell Responses in Children Compared with Adults 175
Structural determinants driving the binding process between PDZ domain of wild type human PALS1 protein and SLiM sequences of SARS-CoV E proteins 173
PDZ2-conjugated-PLGA nanoparticles are tiny heroes in the battle against SARS-CoV-2 171
Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection 170
Direct MALDI-TOF MS Testing from Positive Blood Cultures for Rapid Identification of Bloodstream Infection-Causing Anaerobic Bacteria 169
Epidemiology of group A streptococcal infection: are we ready for a new scenario? 167
Celiac Disease Predisposition and Genital Tract Microbiota in Women Affected by Recurrent Pregnancy Loss 167
PE-PGRS33 contributes to Mycobacterium tuberculosis entry in macrophages through interaction with TLR2 164
PE_PGRS3 of Mycobacterium tuberculosis is specifically expressed at low phosphate concentration, and its arginine-rich C-terminal domain mediates adhesion and persistence in host tissues when expressed in Mycobacterium smegmatis 161
Pilot study on cultural and metagenomic analysis of bile and biliary stents lead to unveiling the key players in stent occlusion 158
Multicenter Evaluation of Anyplex Plus MTB/NTM MDR-TB Assay for Rapid Detection of Mycobacterium tuberculosis Complex and Multidrug-Resistant Isolates in Pulmonary and Extrapulmonary Specimens 158
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features 153
Microbial signature of plaque and gut in acute coronary syndrome 145
Impact of protein domains on PE_PGRS30 polar localization in Mycobacteria 145
Vacuum-assisted closure (VAC®) systems and microbiological isolation of infected wounds 145
Unraveling the Gut Microbiota: Implications for Precision Nutrition and Personalized Medicine 144
Accuracy of QuantiFERON-TB Gold-PLUS Test for the Diagnosis of Mycobacterium tuberculosis infection in Children 144
Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients 142
Risk Factors for Mortality in Adult COVID-19 Patients Who Develop Bloodstream Infections Mostly Caused by Antimicrobial-Resistant Organisms: Analysis at a Large Teaching Hospital in Italy 142
Graphene–Curcumin Coatings Resistant to SARS-CoV-2 and Mycobacteria for the Production of Personal Protective Equipment 141
Re-evaluating positive serum samples for SARS-CoV-2-specific IgA and IgG antibodies using an in-house serological assay 141
Evaluation of Novel Guanidino-Containing Isonipecotamide Inhibitors of Blood Coagulation Factors against SARS-CoV-2 Virus Infection 140
Simplified Testing Method for Direct Detection of Carbapenemase-Producing Organisms from Positive Blood Cultures Using the NG-Test Carba 5 Assay 140
The Relationship Between Maternal and Neonatal Microbiota in Spontaneous Preterm Birth: A Pilot Study 139
PE_PGRS3 ensures provision of the vital phospholipids cardiolipin and phosphatidylinositols by promoting the interaction between M. tuberculosis and host cells 139
Verification of the Vitek Reveal System for Direct Antimicrobial Susceptibility Testing in Gram-Negative Positive Blood Cultures 136
Rapid Detection of the Omicron (B.1.1.529) SARS-CoV-2 Variant Using a COVID-19 Diagnostic PCR Assay 135
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in children with household exposure to adults with COVID-19: Preliminary findings 131
Two-Period Study Results from a Large Italian Hospital Laboratory Attesting SARS-CoV-2 Variant PCR Assay Evolution 130
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19 128
Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children 128
Graphene nanoplatelet and graphene oxide functionalization of face mask materials inhibits infectivity of trapped SARS-CoV-2 126
Characterization of Metallo β-Lactamase Producing Enterobacterales Isolates with Susceptibility to the Aztreonam/Avibactam Combination 125
Comparative Fecal Microbiota Analysis of Infants With Acute Bronchiolitis Caused or Not Caused by Respiratory Syncytial Virus 122
Evaluation of Everolimus Activity against Mycobacterium tuberculosis Using In Vitro Models of Infection 120
Rapid and safe one-step extraction method for the identification of Brucella strains at genus and species level by MALDI-TOF mass spectrometry 120
Evaluation of the Toxic Activity of the Graphene Oxide in the Ex Vivo Model of Human PBMC Infection with Mycobacterium tuberculosis 119
First case of bacteremic liver abscess caused by an ST260-related (ST1861), hypervirulent Klebsiella pneumoniae 119
First description of the katG gene deletion in a Mycobacterium tuberculosis clinical isolate and its impact on the mycobacterial fitness 118
IP-10 contributes to the inhibition of mycobacterial growth in an ex vivo whole blood assay 116
Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin 113
Graphene oxide-linezolid combination as potential new anti-tuberculosis treatment 113
Evaluation of PE_PGRS33 as a potential surface target for humoral responses against Mycobacterium tuberculosis 112
Characterization of gut microbiota in patients with metabolic syndrome candidates for bariatric/metabolic surgery: Preliminary findings of a multi-center prospective study 111
Reemergence of Streptococcus pyogenes Infections in a Large Italian Hospital: A déjà vu from past Years 110
Graphene oxide coatings prevent Candida albicans biofilm formation with a controlled release of curcumin-loaded nanocomposites 110
Profiling the gut microbiota to assess infection risk in Klebsiella pneumoniae-colonized patients 107
Gut Microbiome Diversity and Composition Correlates With Time in the Therapeutic Range in Patients on Warfarin Treatment: A Pilot Study 107
In situ N-acetylcysteine release from polyvinyl alcohol film for moisture-activated food packaging 103
Enhanced chemotherapy for glioblastoma multiforme mediated by functionalized graphene quantum dots 103
Original Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross -protection against COVID-19 102
Increasing Detection of Legionnaires’ Disease in a Large Italian Hospital in the Period 2016–2023 102
Immune characterization of the HBHA-specific response in mycobacterium tuberculosis-infected patients with or without HIV infection 98
Optimized Use of the MALDI BioTyper System and the FilmArray BCID Panel for Direct Identification of Microbial Pathogens from Positive Blood Cultures 96
Recommendations for accurate genotyping of SARS-CoV-2 using amplicon-based sequencing of clinical samples 95
Lack of Response to HBHA in HIV-Infected Patients with Latent Tuberculosis Infection 91
Structural Basis of PE_PGRS Polymorphism, a Tool for Functional Modulation 90
Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients 88
The Mycobacterial HBHA Protein: a Promising Biomarker for Tuberculosis 85
First bloodstream infection caused by Prevotella copri in a heart failure elderly patient with Prevotella-dominated gut microbiota: a case report 83
Face masks and nanotechnology: Keep the blue side up 83
PE_PGRS proteins of Mycobacterium tuberculosis: A specialized molecular task force at the forefront of host–pathogen interaction 80
Profiling the Gastrointestinal Microbiota 72
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in children with household exposure to adults with COVID-19: Preliminary findings 68
Short-term gut microbiota's shift after laparoscopic Roux-en-Y vs one anastomosis gastric bypass: results of a multicenter randomized control trial 59
Establishment of Patient-Derived Organoids from Hepatocellular Carcinoma: Preliminary Data on Yield, Histopathological Concordance, and Methodological Challenges 25
Klebsiella genus as driver of human disease: from infections to non-communicable disorders. 21
Informed Therapeutic Microbiome Modulation for Post-Infectious Irritable Bowel Syndrome: Pilot Experience of a Microbiome Clinic 20
Klebsiella genus as driver of human disease: from infections to non-communicable disorders. 17
Elucidating the role of group A Streptococcus genomics and pharyngeal microbiota in acute paediatric pharyngitis 16
Role of Next-Generation Sequencing in Excluding the Nosocomial Origin of a Case of Legionnaires’ Disease Integrating Environmental Surveillance and Clinical Diagnosis 14
Detection of β-lactam resistance genes in Gram-negative bacteria from positive blood cultures using a microchip-based molecular assay 9
The Interplay Between the Gut Microbiota and Colorectal Cancer: A Review of the Literature 8
Bladder Microbiota Snapshots Help to Monitor Urinary Tract Infections in Vulnerable Patients 6
Comparative genomic analysis of bacteriocin genes in Lactobacillus crispatus strains 6
Bloodstream infection by Lactobacillus rhamnosus in a haematology patient: why metagenomics can make the difference 6
The invasive GAS puzzle in Italy: genomic insights from a hospital cohort in a fragmented surveillance landscape 6
Characterization of the Effect of α-Lipoic Acid in Human Macrophages Infected with Mycobacterium tuberculosis 5
From paediatric rebound to adult redistribution: changing the epidemiology of group A Streptococcus after COVID-19 5
Totale 13.155
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.669
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.669
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022573 0 23 29 45 21 28 18 92 38 46 118 115
2022/20231.486 200 180 91 201 82 163 69 98 145 121 94 42
2023/2024998 50 184 31 57 51 158 89 29 23 61 115 150
2024/20252.305 95 53 128 107 136 110 139 119 346 247 447 378
2025/20265.196 691 155 324 689 910 287 846 248 359 318 187 182
2026/2027814 256 558 0 0 0 0 0 0 0 0 0 0
Totale 13.161